Novartis announced today that the US Food and Drug Administration (FDA) has approved Jadenu™ (deferasirox) tablets, a new oral formulation of Exjade® (deferasirox) tablets for oral suspension, for the treatment of chronic iron overload due to blood transfusions in patients 2 years of age and older, and chronic iron overload in non-transfusion-dependent thalassemia syndromes (NTDT) in patients 10 years of age and older. Jadenu is the only once-daily oral iron chelator that can be swallowed whole.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7440151-novartis-jadenu-fda-approval/
"OFFICIAL PARTNER RESMI FIFA WORLD CUP 2018 RUSSIA!
Ayo segera bergabung bersama kami dan Dukung Negara Jagoan kamu hanya di BOLAVITA
Info Lebih Lanjut Bisa Hub CS kami :
wechat : bolavita
whatup : 6281377055002
BBM: BOLAVITA(NEW)"
"Dapatkan berbagai bonus dari POKERVITA
♣♣ Bonus Hariaan Hingga 3juta
♣♣ Bonus Bulanan Hadiah Spesial untuk member yang bermain selama 1 bulan penuh
♣♣ Bonus cashback 0.5 % (Mingguan)
♣♣ Bonus Referensi 20% (Seumur hidup)
Contact Us Person :
? WA: 082312256064
? BBM : D88B0154"
